NCT03978663View on ClinicalTrials.gov

Three Fraction Radiation to Induce Immuno-Oncologic Response

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
High-Risk CancerLocally Advanced Breast Cancer
Interventions
RADIATION

Neoadjuvant radiotherapy

Neoadjuvant radiation therapy delivered to a portion of the index tumour for high-risk breast carcinoma for immune priming prior to neoadjuvant radiation

Trial Locations (1)

Unknown

London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER